PBAX

Phoenix Biotech Acquisition Corp. [PBAX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

PBAX Stock Summary

In the News

PBAX Financial details

Company Rating
Sell
Market Cap
36.47M
Income
-2.41M
Revenue
254.83K
Book val./share
-0.87
Cash/share
1.33
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-29.04
Forward P/E
-
PEG
-0.13
P/S
270.6
P/B
-12.76
P/C
4.4
P/FCF
-40.32
Quick Ratio
0.02
Current Ratio
1.76
Debt / Equity
-0.25
LT Debt / Equity
-
-
-
EPS (TTM)
-0.33
EPS next Y
-
EPS next Q
1.58
EPS this Y
172.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-74.9%
-
-
-
-
SMA20
-32.61%
SMA50
-31.25%
SMA100
-
Inst Own
9.97%
Inst Trans
0.6%
ROA
-28%
ROE
2027%
ROC
-0.36%
Gross Margin
100%
Oper. Margin
-520%
Profit Margin
-945%
Payout
-
Shs Outstand
6.23M
Shs Float
940.12K
-
-
-
-
Target Price
-
52W Range
4.12-12.8
52W High
-51.25%
52W Low
+46.25%
RSI
29.6
Rel Volume
0.76
Avg Volume
8.08K
Volume
6.12K
Perf Week
-40.37%
Perf Month
-46.82%
Perf Quarter
-
Perf Half Y
-46.48%
-
-
-
-
Beta
0.044
-
-
Volatility
1.9%, 2.1%
Prev Close
4.65%
Price
5.85
Change
16.77%

PBAX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2021-12-31 2022-12-31
2.02K2.02K
Revenue per share
00.01
Net income per share
-0.01-0.04
Operating cash flow per share
-0.03-0.06
Free cash flow per share
-0.03-0.06
Cash per share
0.050.03
Book value per share
7.430.14
Tangible book value per share
7.430.14
Share holders equity per share
7.430.14
Interest debt per share
00.04
Market cap
227.74M183.8M
Enterprise value
226.65M183.97M
P/E ratio
-721.74-275.25
Price to sales ratio
0721.25
POCF ratio
-326.7-168.27
PFCF ratio
-326.7-168.27
P/B Ratio
1.3374.45
PTB ratio
1.3374.45
EV to sales
0721.93
Enterprise value over EBITDA
-682.61-32.04
EV to operating cash flow
-325.12-168.43
EV to free cash flow
-325.12-168.43
Earnings yield
00
Free cash flow yield
0-0.01
Debt to equity
00.26
Debt to assets
00.02
Net debt to EBITDA
3.31-0.03
Current ratio
13.881.38
Interest coverage
00
Income quality
2.211.64
Dividend Yield
00
Payout ratio
00
Sales general and administrative to revenue
011.15
Research and developement to revenue
00
Intangibles to total assets
00
Capex to operating cash flow
00
Capex to revenue
00
Capex to depreciation
00
Stock based compensation to revenue
00
Graham number
1.520.34
ROIC
0-0.21
Return on tangible assets
0-0.02
Graham Net
-0.35-2.2
Working capital
1.26M11.62M
Tangible asset value
170.83M2.47M
Net current asset value
-7.89M2.47M
Invested capital
00.26
Average receivables
00
Average payables
0833.78K
Average inventory
00
Days sales outstanding
00
Days payables outstanding
00
Days of inventory on hand
00
Receivables turnover
00
Payables turnover
00
Inventory turnover
00
ROE
0-0.27
Capex per share
00

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00.01000
Net income per share
0-0.01-0.06-0.21-0.05
Operating cash flow per share
-0.01-0.02-0.03-0.13-0.04
Free cash flow per share
-0.01-0.02-0.03-0.13-0.04
Cash per share
7.840.022.12.071.33
Book value per share
7.420.110.290.08-0.87
Tangible book value per share
7.420.110.290.08-0.87
Share holders equity per share
7.420.110.290.08-0.87
Interest debt per share
00.030.080.170.22
Market cap
231.88M236.02M72.3M73.79M68.77M
Enterprise value
231.37M236.19M72.77M74.86M70.05M
P/E ratio
686-224.63-48.44-12.83-51.47
Price to sales ratio
0926.17000
POCF ratio
-1.33K-632.58-365.56-83.56-268.51
PFCF ratio
-1.33K-632.58-365.56-83.56-268.51
P/B Ratio
1.3695.636.39134.34-12.55
PTB ratio
1.3695.636.39134.34-12.55
EV to sales
0926.86000
Enterprise value over EBITDA
-154.47-73.62-123.28-48.5-162.97
EV to operating cash flow
-1.33K-633.05-367.94-84.77-273.49
EV to free cash flow
-1.33K-633.05-367.94-84.77-273.49
Earnings yield
00-0.01-0.020
Free cash flow yield
000-0.010
Debt to equity
00.260.332.14-0.25
Debt to assets
00.020.050.080.16
Net debt to EBITDA
0.34-0.05-0.8-0.69-2.97
Current ratio
0.91.384.383.21.76
Interest coverage
03.715.4400
Income quality
-2.061.420.410.610.77
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
05.39000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.780.170.60.621.01
ROIC
0-0.12-0.17-0.92-0.11
Return on tangible assets
0-0.01-0.03-0.1-0.04
Graham Net
7.4-1.720.260.07-0.87
Working capital
-90.68K11.62M11.14M9.7M3.67M
Tangible asset value
170.43M2.47M1.99M549.25K-5.48M
Net current asset value
-9.24M2.47M1.99M549.25K-5.48M
Invested capital
00.260.332.14-0.25
Average receivables
00000
Average payables
436.68K1.18M1.84M2.58M3.23M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0-0.11-0.19-2.620.06
Capex per share
00000

PBAX Frequently Asked Questions

What is Phoenix Biotech Acquisition Corp. stock symbol ?

Phoenix Biotech Acquisition Corp. is a US stock , located in Oakland of Ca and trading under the symbol PBAX

What is Phoenix Biotech Acquisition Corp. stock quote today ?

Phoenix Biotech Acquisition Corp. stock price is $5.85 today.

Is Phoenix Biotech Acquisition Corp. stock public?

Yes, Phoenix Biotech Acquisition Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap